Lawrence Otto Klein is CBO & COO of CRISPR Therapeutics AG. Currently has a direct ownership of 26,797 shares of CRSP, which is worth approximately $1.39 Million. The most recent transaction as insider was on Mar 14, 2022, when has been sold 1,229 shares (Common Shares) at a price of $61.08 per share, resulting in proceeds of $75,067. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.8K
0% 3M change
0% 12M change
Total Value Held $1.39 Million

Lawrence Otto Klein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2022
SELL
Payment of exercise price or tax liability
$75,067 $61.08 p/Share
1,229 Reduced 4.39%
26,797 Common Shares
Mar 11 2022
SELL
Payment of exercise price or tax liability
$117,800 $62.56 p/Share
1,883 Reduced 7.0%
25,026 Common Shares
Mar 11 2022
BUY
Exercise of conversion of derivative security
-
3,000 Added 9.67%
28,026 Common Shares
Mar 10 2022
BUY
Exercise of conversion of derivative security
-
4,584 Added 14.56%
26,909 Common Shares
Dec 06 2021
SELL
Payment of exercise price or tax liability
$773,666 $69.17 p/Share
11,185 Reduced 33.38%
22,325 Common Shares
Dec 03 2021
BUY
Exercise of conversion of derivative security
-
26,667 Added 44.31%
33,510 Common Shares
Sep 13 2021
SELL
Payment of exercise price or tax liability
$495,837 $117.86 p/Share
4,207 Reduced 38.07%
6,843 Common Shares
Sep 10 2021
BUY
Exercise of conversion of derivative security
-
10,000 Added 47.51%
11,050 Common Shares
Mar 23 2021
SELL
Open market or private sale
$12,758,000 $127.58 p/Share
100,000 Reduced 98.96%
1,050 Common Shares
Mar 23 2021
BUY
Exercise of conversion of derivative security
$2,918,960 $33.17 p/Share
88,000 Added 46.55%
101,050 Common Shares
Mar 10 2021
SELL
Payment of exercise price or tax liability
$265,805 $124.15 p/Share
2,141 Reduced 14.09%
13,050 Common Shares
Mar 10 2021
BUY
Exercise of conversion of derivative security
-
4,583 Added 23.18%
15,191 Common Shares
Jan 15 2021
SELL
Open market or private sale
$5,382,000 $215.28 p/Share
25,000 Reduced 55.56%
20,000 Common Shares
Jan 15 2021
BUY
Exercise of conversion of derivative security
$337,635 $13.5 p/Share
25,010 Added 40.77%
36,334 Common Shares
Jan 02 2021
SELL
Payment of exercise price or tax liability
$1,438,009 $153.11 p/Share
9,392 Reduced 46.96%
10,608 Common Shares
Jun 25 2020
SELL
Open market or private sale
$369,284 $75.18 p/Share
4,912 Reduced 19.72%
20,000 Common Shares
Jun 25 2020
BUY
Exercise of conversion of derivative security
$61,744 $12.57 p/Share
4,912 Added 16.47%
24,912 Common Shares
Jun 24 2020
SELL
Open market or private sale
$4,940,830 $75.91 p/Share
65,088 Reduced 76.49%
20,000 Common Shares
Jun 24 2020
BUY
Exercise of conversion of derivative security
$600,111 $9.22 p/Share
65,088 Added 58.37%
46,422 Common Shares
May 11 2020
SELL
Open market or private sale
$1,518,250 $60.73 p/Share
25,000 Reduced 55.56%
20,000 Common Shares
May 11 2020
BUY
Exercise of conversion of derivative security
$146,500 $5.86 p/Share
25,000 Added 35.71%
45,000 Common Shares
Jul 11 2019
SELL
Open market or private sale
$421,134 $50.01 p/Share
8,421 Reduced 29.63%
20,000 Common Shares
Jul 11 2019
BUY
Exercise of conversion of derivative security
$49,347 $5.86 p/Share
8,421 Added 22.86%
28,421 Common Shares
Jul 10 2019
SELL
Open market or private sale
$579,182 $50.02 p/Share
11,579 Reduced 36.67%
20,000 Common Shares
Jul 10 2019
BUY
Exercise of conversion of derivative security
$67,853 $5.86 p/Share
11,579 Added 26.83%
31,579 Common Shares

Also insider at

DYN
Dyne Therapeutics, Inc. Healthcare
JSPR
Jasper Therapeutics, Inc. Healthcare
LOK

Lawrence Otto Klein

CBO & COO
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP